SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities
SEC Accession No. 0001476860-10-000008
Filing Date
2010-12-08
Accepted
2010-12-08 18:51:08
Documents
1
Period of Report
2010-12-06
Filing Date Changed
2010-12-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 10970
  Complete submission text file 0001476860-10-000008.txt   12981
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address OCEAN ONE, UNIT 304, MAXWELL COAST ROAD OISTINS C8 BB17154
Business Address
Wells William McDowall (Reporting) CIK: 0001476860 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 101240898